GenePlanet

-
Company
GenePlanet
-
Fund
BPC II
-
Sector
Biotechnology
-
Status
Invested
-
Country
Slovenia
GenePlanet is the leading CEE provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests. The company was founded in 2008 with the vision of enabling more and more people around the world to discover their DNA.
With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts.
With a presence in more than 35 countries worldwide and over 100,000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.
GenePlanet’s mission is to continue to provide cutting-edge genetic testing solutions that enable individuals to make informed decisions about their health and well-being.
For more info, please visit: geneplanet.com/eu